KOSTAIVE

This brand name is authorized in Lithuania

Active ingredients

The drug KOSTAIVE contains one active pharmaceutical ingredient (API):

1 Zapomeran UNII J9E7RSF8K3 - ZAPOMERAN

Zapomeran is composed of a self-amplifying mRNA encoding the spike protein of SARS-CoV-2, encapsulated in lipid nanoparticles. The self-amplifying mRNA is designed to produce extra copies of mRNA within the host cells after intramuscular injection, to achieve enhanced expression of the spike protein antigen. Read about Zapomeran

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KOSTAIVE Powder for dispersion for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BN01		J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BN Covid-19 vaccines
Discover more medicines within J07BN01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1102756